Page last updated: 2024-11-02

pd 169316 and Leukemia, Promyelocytic, Acute

pd 169316 has been researched along with Leukemia, Promyelocytic, Acute in 1 studies

2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole: p38 MAP kinase inhibitor

Leukemia, Promyelocytic, Acute: An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Xiao, C1
Zhong, L1
Shan, Z1
Xu, T1
Gan, L1
Song, H1
Yang, R1
Li, L1
Liu, B1

Other Studies

1 other study available for pd 169316 and Leukemia, Promyelocytic, Acute

ArticleYear
NLS-RARα Inhibits the Effects of All-trans Retinoic Acid on NB4 Cells by Interacting with P38α MAPK.
    International journal of medical sciences, 2016, Volume: 13, Issue:8

    Topics: Cell Differentiation; Cell Line, Tumor; Drug Resistance, Neoplasm; Gene Expression Regulation, Neopl

2016